MEK抑制剂-话题@MedSci

#MEK抑制剂#

22篇内容 | 1848人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1512727, encodeId=85641512e2762, content=<a href='/topic/show?id=c3e91152873' target=_blank style='color:#2F92EE;'>#MEK抑制剂#</a>, objectTitle=Clin Cancer Res：AZD9291联合MEK抑制剂克服包含C797S的获得性耐药, objectType=article, longId=115437, objectId=65d511543e88, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65d511543e88, replyNumber=0, likeNumber=64, createdTime=2017-10-10, rootId=0, userName=ms2186806800017884, userId=318b10497059, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65d511543e88, moduleTitle=Clin Cancer Res：AZD9291联合MEK抑制剂克服包含C797S的获得性耐药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65d511543e88)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1512726, encodeId=47171512e263a, content=<a href='/topic/show?id=c3e91152873' target=_blank style='color:#2F92EE;'>#MEK抑制剂#</a>, objectTitle=Clin Cancer Res：MEK抑制剂单独或联合mTOR抑制剂对头颈部鳞状细胞癌的抗肿瘤作用, objectType=article, longId=50869, objectId=694b508695d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=694b508695d, replyNumber=0, likeNumber=77, createdTime=2015-05-19, rootId=0, userName=ms2186806800017884, userId=318b10497059, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=694b508695d, moduleTitle=Clin Cancer Res：MEK抑制剂单独或联合mTOR抑制剂对头颈部鳞状细胞癌的抗肿瘤作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=694b508695d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1512725, encodeId=312f1512e2525, content=<a href='/topic/show?id=c3e91152873' target=_blank style='color:#2F92EE;'>#MEK抑制剂#</a>, objectTitle=Ann Oncol：MEK抑制剂trametinib对KRAS突变的非小细胞肺癌的II期临床研究, objectType=article, longId=47689, objectId=936f4e689f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=936f4e689f6, replyNumber=0, likeNumber=74, createdTime=2015-03-05, rootId=0, userName=ms2186806800017884, userId=318b10497059, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=936f4e689f6, moduleTitle=Ann Oncol：MEK抑制剂trametinib对KRAS突变的非小细胞肺癌的II期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=936f4e689f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1512724, encodeId=27531512e2472, content=<a href='/topic/show?id=c3e91152873' target=_blank style='color:#2F92EE;'>#MEK抑制剂#</a>, objectTitle=Lancet ：MEK抑制剂Trametinib的Ⅱ期临床试验推荐剂量确定, objectType=article, longId=8271, objectId=29cd82e153, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29cd82e153, replyNumber=0, likeNumber=76, createdTime=2012-07-29, rootId=0, userName=ms2186806800017884, userId=318b10497059, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29cd82e153, moduleTitle=Lancet ：MEK抑制剂Trametinib的Ⅱ期临床试验推荐剂量确定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29cd82e153)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1512723, encodeId=a2501512e23be, content=<a href='/topic/show?id=c3e91152873' target=_blank style='color:#2F92EE;'>#MEK抑制剂#</a>, objectTitle=BJC：联合使用ALK和MEK抑制剂治疗非小细胞肺癌, objectType=article, longId=4106, objectId=c962410668, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c962410668, replyNumber=0, likeNumber=57, createdTime=2012-02-26, rootId=0, userName=ms2186806800017884, userId=318b10497059, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c962410668, moduleTitle=BJC：联合使用ALK和MEK抑制剂治疗非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c962410668)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

MEK抑制剂

2020-05-29

ms2186806800017884 (审核中...)

前往app查看评论内容

#MEK抑制剂#

Clin Cancer Res：AZD9291联合MEK抑制剂克服包含C797S的获得性耐药

2017-10-10

ms2186806800017884 (审核中...)

前往app查看评论内容

#MEK抑制剂#

Clin Cancer Res：MEK抑制剂单独或联合mTOR抑制剂对头颈部鳞状细胞癌的抗肿瘤作用

2015-05-19

ms2186806800017884 (审核中...)

前往app查看评论内容

#MEK抑制剂#

Ann Oncol：MEK抑制剂trametinib对KRAS突变的非小细胞肺癌的II期临床研究

2015-03-05

ms2186806800017884 (审核中...)

前往app查看评论内容

#MEK抑制剂#

Lancet ：MEK抑制剂Trametinib的Ⅱ期临床试验推荐剂量确定

2012-07-29

ms2186806800017884 (审核中...)

前往app查看评论内容

#MEK抑制剂#

BJC：联合使用ALK和MEK抑制剂治疗非小细胞肺癌

2012-02-26

科室
- - 订阅+
  - 更多科室
工具
服务